论文部分内容阅读
目的:探讨爱迪注射液胸腔及静脉注射对肺癌胸水的疗效差异。方法:回顾性分析1998年5月～2003年8月收治的肺癌胸水住院患者的临床资料。结果:22例肺癌胸水患者经胸腔注射爱迪注射液治疗后有效率达77.3%,27例经静脉注射治疗后有效率达29.6%。结论:爱迪注射液胸腔注射治疗肺癌胸水疗效优于静脉注射治疗,且副作用小,可作为治疗恶性胸水的一种较好方法。
Objective: To investigate the effect of Aidi injection thoracic cavity and intravenous injection on lung cancer pleural effusion. Methods: The clinical data of hospitalized patients with lung cancer pleural fluid admitted from May 1998 to August 2003 were retrospectively analyzed. Results: The effective rate was 77.3% after 22 cases of lung cancer pleural effusion treated with Aidi injection. The effective rate was 29.6% after 27 cases treated with intravenous injection. Conclusion: Aidi injection is more effective than intravenous injection in the treatment of lung cancer pleural effusion with less side effects. It can be used as a better method for the treatment of malignant pleural effusion.